PATENTS OFFICE JOURNAL - Irish Patents Office

(No. 1987) Patents Office Journal (11/02/2004)
S83301 A veneered product. Int.Cl.7 B32B 3/14;B27D 1/00. BRIAN LENEHAN 21
March 2003 (S20030210) [IRELAND-22 March 2002]
83302 Irradiation apparatus for production line use. Int.Cl.7 G21K 5/00;H01J
37/20;H01J 37/30. I-AX TECHNOLOGIES 24 November 1999 (19990987)
[UNITED STATES OF AMERICA-3 December 1998]
83303 IGF-1 receptor interacting proteins (IIPs), genes coding thereof and uses thereof.
Int.Cl.7 C12N 15/12;A61K 38/17;A61P 35/00;C12Q 1/68;G01N 33/574;C07K
14/435;//C07K 14/65;C07K 14/72. F. HOFFMANN-LA ROCHE AG 2
December 1999 (19991020) [EUROPEAN PATENT OFFICE (EPO)-3
December 1998]
83304 Pharmaceutical compositions comprising calcitonin. Int.Cl.7 A61K 38/23;C07K
14/585. NOVARTIS AG 22 April 1992 (19921278) [UNITED KINGDOM-23
April 1991]
83305 Fire retardant doors. Int.Cl.6 E06B 5/16. CUMAR TEICHNEOLAIOCHT
TEORANTA 7 September 1999 (19990753) [IRELAND-7 September 1998]
83306 The ciliary neurotrophic factor receptor. Int.Cl.7 C12N 15/12;C12N 5/10;C07K
14/71;C12Q 1/68;G01N 33/53;A61K 38/17;A61K 48/00;A61P 25/00.
REGENERON PHARMACEUTICALS, INC 31 May 1991 (19911867)
[UNITED STATES OF AMERICA-1 June 1990 UNITED STATES OF
AMERICA-28 March 1991 UNITED STATES OF AMERICA-15 May 1991]
83307 Process for the biochemical oxidation of steroids and genetically engineered cells
to be used therefor. Int.Cl.7 C12N 15/53;C12N 9/02;C12P 33/16;C12P
33/18;C12N 1/21;C12N 1/19;C12N 5/10;//(C12N 1/21, C12R 1:19;C12R
1:07)(C12N 1/19, C12R 1:85). AVENTIS PHARMA S.A. 5 May 1989
(19891470) [EUROPEAN PATENT OFFICE (EPO)-6 May 1988 EUROPEAN
PATENT OFFICE (EPO)-23 September 1988]
83308 Bioconversions catalyzed by the toluene monooxygenase of pseudomonas
mendocina KR-1. Int.Cl.7 C12N 15/53;C12N 9/02;C12N 1/21;C12P 7/22;C12P
7/42;//(C12N 15/53, C12R 1:38). AMGEN INC. 21 August 1991 (19912966)
[UNITED STATES OF AMERICA-28 September 1990]
2734